Empresa Anebulo Pharmaceuticals, Inc.
Acciones
ANEB
US0345691036
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,83 USD | +1,07 % | +38,12 % | +16,94 % |
Resumen de negocios
Número de empleados: 2
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joseph Lawler
FOU | Founder | 52 | 23/04/20 |
Chief Executive Officer | 54 | 05/10/23 | |
Daniel George
DFI | Director of Finance/CFO | 54 | 28/09/23 |
Kenneth Cundy
CTO | Chief Tech/Sci/R&D Officer | 65 | 20/05/22 |
Madison Damour
IRC | Investor Relations Contact | - | - |
Scott Anderson
IRC | Investor Relations Contact | - | 06/01/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jason Aryeh
BRD | Director/Board Member | 55 | 01/03/21 |
Kenneth Lin
BRD | Director/Board Member | 51 | 01/02/21 |
Bimal Shah
BRD | Director/Board Member | 48 | 05/10/23 |
Chief Executive Officer | 54 | 05/10/23 | |
Director/Board Member | 42 | 01/11/22 | |
Karah Parschauer
BRD | Director/Board Member | 46 | 01/02/21 |
Joseph Lawler
FOU | Founder | 52 | 23/04/20 |
Aron English
BRD | Director/Board Member | 41 | 01/06/20 |
Areta Kupchyk
BRD | Director/Board Member | 67 | 01/04/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 25 933 217 | 8 978 689 ( 34,62 %) | 0 | 34,62 % |
Información de la empresa
Anebulo Pharmaceuticals, Inc.
1017 Ranch Road 620 South Suite 107
78734, Lakeway
+(512) 598-0931
http://www.anebulo.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+16,94 % | 73,39 M | |
+23,13 % | 46,93 mil M | |
+37,69 % | 39,08 mil M | |
-8,73 % | 38,48 mil M | |
+28,09 % | 31,01 mil M | |
-12,26 % | 26,14 mil M | |
+10,57 % | 25,88 mil M | |
+45,05 % | 14,15 mil M | |
+32,23 % | 12,53 mil M | |
-6,56 % | 11,36 mil M |
- Bolsa de valores
- Acciones
- Acción ANEB
- Empresa Anebulo Pharmaceuticals, Inc.